Do JAK inhibitors affect immune response to COVID-19 vaccination? Data from the MAJIK-SFR Registry

SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response

(2021) Michael Markus Bonelli et al.   ANNALS OF THE RHEUMATIC DISEASES

Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study

(2021) Victoria Furer et al.   ANNALS OF THE RHEUMATIC DISEASES

Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis

(2021) Serena Bugatti et al.   ANNALS OF THE RHEUMATIC DISEASES

A Systematic Review and Metaanalysis of Antirheumatic Drugs and Vaccine Immunogenicity in Rheumatoid Arthritis

(2018) Sujith Subesinghe et al.   JOURNAL OF RHEUMATOLOGY

The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis

(2015) Kevin L Winthrop et al.   ANNALS OF THE RHEUMATIC DISEASES

Effect of Methotrexate, Anti-Tumor Necrosis Factor α, and Rituximab on the Immune Response to Influenza and Pneumococcal Vaccines in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

(2013) Charlotte Hua et al.   ARTHRITIS CARE & RESEARCH